This article was published online March 8, 2011. An error was subsequently identified. This notice is included in the online and print versions to indicate that both have been corrected November 22, 2011.
1097-0215/asset/olbannerleft.jpg?v=1&s=45719cd7de57873027993264fcc568b335a8cd56)
1097-0215/asset/olbannerright.jpg?v=1&s=5e0fba63c1309b3036eb9215a0e1e83dd02efd19)
Carcinogenesis
You have full text access to this OnlineOpen article
Anti-tumor efficacy of naked siRNAs for ERBB3 or AKT2 against lung adenocarcinoma cell xenografts†
Article first published online: 28 MAY 2011
DOI: 10.1002/ijc.26041
Copyright © 2011 UICC
Additional Information
How to Cite
Sithanandam, G., Fornwald, L. W., Fields, J. R., Morris, N. L. and Anderson, L. M. (2012), Anti-tumor efficacy of naked siRNAs for ERBB3 or AKT2 against lung adenocarcinoma cell xenografts. Int. J. Cancer, 130: 251–258. doi: 10.1002/ijc.26041
- †
Publication History
- Issue published online: 23 NOV 2011
- Article first published online: 28 MAY 2011
- Accepted manuscript online: 8 MAR 2011 10:43AM EST
- Manuscript Accepted: 31 JAN 2011
- Manuscript Revised: 13 JAN 2011
- Manuscript Received: 1 NOV 2010
Funded by
- National Institutes of Health (Intramural Research Program, Federal funds). Grant Number: HHSN261200800001E
- Abstract
- Article
- References
- Supporting Information
- Cited By
Additional Supporting Information may be found in the online version of this article.
| Filename | Format | Size | Description |
|---|---|---|---|
| IJC_26041_sm_suppinfotable1.doc | 47K | Supporting Information Table 1. |
Please note: Wiley-Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.